Lin Patrick
SEC CIK 1799363 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | Chief Business - Strategy Off | 13.1K | $147.4K | — | 28 | 2021-08-05 | 2026-06-30 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:19 | 2026-06-30 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $1.93 | +2,106 | 13.1K | +19% | +$4,065 | |
| 2026-06-16 16:21 | 2026-06-15 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.22 | +1,831 | 11.0K | +20% | +$4,065 | |
| 2026-06-01 16:56 | 2026-05-29 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.57 | +1,582 | 9,176 | +21% | +$4,066 | |
| 2026-05-19 18:02 | 2026-05-15 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.97 | +1,369 | 7,594 | +22% | +$4,066 | |
| 2026-05-01 16:36 | 2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.69 | +1,511 | 6,236 | +32% | +$4,065 | |
| 2026-04-17 16:52 | 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.97 | +1,369 | 4,725 | +41% | +$4,066 | |
| 2026-04-01 17:11 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.54 | +1,603 | 3,356 | +91% | +$4,064 | |
| D | 2026-02-04 | 2026-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | M - OptEx | $0.00 | +193 | 1,753 | +12% | $0 |
| 2025-04-11 | 2025-04-01 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | M - OptEx | — | +14.5K | 43.5K | +50% | — | |
| 2025-04-11 | 2025-04-01 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | F - Tax | $0.41 | -4,814 | 38.7K | -11% | -$1,974 | |
| I | 2025-01-29 | 2025-01-27 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $0.8 | +43.5K | 43.5K | New | +$34.8K |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | F - Tax | $2.43 | -810 | 28.7K | -3% | -$1,967 |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | M - OptEx | — | +2,319 | 29.3K | +9% | — |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | F - Tax | $2.79 | -539 | 28.6K | -2% | -$1,504 |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | M - OptEx | — | +1,675 | 29.2K | +6% | — |
| M | 2024-02-01 | 2024-01-31+ | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.38 | +4,000 | 27.5K | +17% | +$9,525 |
| 2023-10-12 | 2023-10-12 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | A - Grant | $0.32 | +5,000 | 469.5K | +1% | +$1,600 | |
| 2023-10-10 | 2023-10-10 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | A - Grant | $0.21 | +13.7K | 464.5K | +3% | +$2,877 | |
| 2023-02-10 | 2023-02-09 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | A - Grant | $0.8 | +12.5K | 450.8K | +3% | +$10.0K | |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | F - Tax | $3.17 | -2,656 | 438.3K | -0.6% | -$8,420 | |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | M - OptEx | — | +7,601 | 441.0K | +2% | — | |
| 2022-05-19 | 2022-05-17 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $1.59 | +2,000 | 433.4K | +0.5% | +$3,180 | |
| M | 2022-04-08 | 2022-04-06+ | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $3.29 | +2,000 | 431.4K | +0.5% | +$6,588 |
| 2022-01-04 | 2021-12-14 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $4.00 | +3,000 | 429.4K | +0.7% | +$12.0K | |
| 2021-12-16 | 2021-12-14 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $4.00 | +3,000 | 429.4K | +0.7% | +$12.0K | |
| 2021-12-07 | 2021-12-03 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $4.80 | +3,500 | 426.4K | +0.8% | +$16.8K | |
| 2021-08-30 | 2021-08-26 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $6.02 | +4,000 | 422.9K | +1.0% | +$24.1K | |
| 2021-08-09 | 2021-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | A - Grant | — | +7,601 | 418.9K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations